Medicus Pharma Ltd.
MDCXNasdaqCIK 1997296HealthcareFiscal year ends Dec 31
Reports and events: 59 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:16 ET | DEF 14A | Proxy statementPeriod 2026-12-02 | 0001062993-26-005627 |
| 2026-10-2317:15 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005528 |
| 2026-10-1616:55 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001062993-26-005382 |
| 2026-10-0716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-005226 |
| 2026-09-1416:39 ET | SCHEDULE 13D | Ownership report, active investor | 0000950142-26-002546 |
| 2026-09-1408:05 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001062993-26-004906 |
| 2026-09-1108:00 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-004898 |
| 2026-09-0308:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062993-26-004806 |
| 2026-08-1217:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001062993-26-004230 |
| 2026-06-0416:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062993-26-003060 |
| 2026-05-2716:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-002900 |
| 2026-05-1416:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001062993-26-002629 |
| 2026-05-0419:00 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001062993-26-002277 |
| 2026-04-2917:21 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001062993-26-002212 |
| 2026-04-2417:27 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-002142 |
| 2026-03-2516:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001062993-26-001606 |
| 2026-03-0616:40 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-26-001326 |
| 2025-12-3009:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001062993-25-017492 |
| 2025-12-0816:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017219 |
| 2025-12-0108:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017085 |
| 2025-11-1917:00 ET | S-1 | Registration statement | 0001062993-25-016962 |
| 2025-11-1417:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-016864 |
| 2025-11-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001062993-25-016838 |
| 2025-10-1716:30 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-25-016179 |
| 2025-09-2917:08 ET | S-1 | Registration statement | 0001062993-25-015841 |
| 2025-09-2917:04 ET | S-1 | Registration statement | 0001062993-25-015839 |
| 2025-09-1808:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-015700 |
| 2025-09-1217:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001062993-25-015601 |
| 2025-09-0214:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-015149 |
| 2025-08-2216:31 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-014806 |
| 2025-08-1116:24 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001062993-25-014058 |
| 2025-08-0407:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-013468 |
| 2025-07-3006:57 ET | 8-K | 8.01 Other events | 0001062993-25-013266 |
| 2025-07-2308:22 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-013073 |
| 2025-07-1408:58 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001062993-25-012767 |
| 2025-07-0315:14 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001062993-25-012533 |
| 2025-06-3016:30 ET | DEF 14A | Proxy statementPeriod 2025-07-22 | 0001062993-25-012273 |
| 2025-06-3013:51 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-012231 |
| 2025-06-2316:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-012044 |
| 2025-06-2016:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001062993-25-011991 |
| 2025-06-0516:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001062993-25-011051 |
| 2025-06-0216:58 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-010687 |
| 2025-05-2716:55 ET | S-1 | Registration statement | 0001062993-25-010394 |
| 2025-05-2713:16 ET | S-1 | Registration statement | 0001062993-25-010333 |
| 2025-05-1217:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001062993-25-009125 |
| 2025-05-0509:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001062993-25-008436 |
| 2025-04-3014:24 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001062993-25-008246 |
| 2025-04-2809:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-008086 |
| 2025-03-2816:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001062993-25-006485 |
| 2025-03-2520:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-25-006170 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.